Market Summary: The global market for the manufacturing of viral vectors and plasmid Deoxyribonucleic Acid (DNA) was valued at USD 1.3 billion in 2022 and is projected to reach USD 8.07 billion by 2032, with a compound annual growth rate (CAGR) of 22.5% during the forecast period. Key drivers include the increasing prevalence of chronic diseases, growing demand for gene therapy, and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian